Agena Bioscience Partners With N-of-One on MassArray Data Interpretation

NEW YORK (GenomeWeb) – N-of-One has entered into a partnership to help Agena Bioscience interpret cancer genomic data generated by its MassArray system, the companies announced today.

Agena’s MassArray is a research-use-only platform designed to detect genetic variation with end-point PCR and label-free mass spectrometry. The deal with N-of-One is designed to support the expansion of MassArray Insights, a recently launched reporting network through which Agena seeks to collaborate with various molecular analysis platform providers.

“MassArray Insights is part of Agena Bioscience’s continued effort to support our CLIA-high complexity certified lab customers who are tackling the challenges presented in molecular diagnostics,” Agena CEO Pete Dansky said in a statement. “We are happy to partner with … N-of-One to help bring our lab clients an important component that nicely follows the value of our test: an evidence-based, clinically actionable report.”

Specific terms of the deal were not disclosed.

In September, Agena signed on Molecular Health as the first interpretation software provider for MassArray Insights.

Be the first to comment

Leave a Reply

Your email address will not be published.